Researchers in the Krementsov Lab have found that a bacterial species called Lactobacillus reuteri, commonly used in probiotics, can increase disease severity in a mouse model of multiple sclerosis (MS), an autoimmune disease that is the leading cause of non-traumatic neurological disability in young adults.
A new publication review series co-edited by Eyal Amiel, an associate professor of medical laboratory science, explores the impact of immunometabolism in the interaction between host and pathogen and casts new light on infection and immune cell activity.
The newly launched publication, Frontiers in Rehabilitation Sciences, selected Reuben Escorpizo, a clinical associate professor and Interim Physical Therapy Program Director in the Department of Rehabilitation and Movement Science, to serve on the journal's editori
- Spotlight On: Alyssa Oviedo ‘22
- Front and Center
- Antiracism and Healthcare
- Free Integrative Health and Wellness Coaching
- UVM Receives $19.4 Million NIH Grant to Promote Biomedical Research and Education in Vermont
- CNHS Welcomes New Faculty
- Bridging the Gaps
- New $5.4 Million NIH Grant Funds UVM Center for Biomedical Shared Resources
- Meet the Class of 2024
- Meet Lauren Rauert '22
- 1 of 63
- next ›